Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burcu Isler

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Modern Rheumatology Case Reports|June 26, 2026
Immunoglobulin A vasculitis in association with invasive meningococcal disease: a case reportJoseph Danicic, Burcu Isler, Jennifer Ng
Current Opinion in Infectious Diseases|February 19, 2020
New treatment options for multiresistant gram negativesDavid L Paterson, Burcu Isler, Adam Stewart
BMC Public Health|February 19, 2020
Limits of the social-benefit motive among high-risk patients: a field experiment on influenza vaccination behaviourOzan Isler, Burcu Isler, Orestis Kopsacheilis, et al.
Infectious Disease Clinics of North America|December 11, 2025
Antimicrobial Management Strategies for Multidrug-Resistant Gram-positive Prosthetic Device InfectionsBurcu Isler, Peter Simos, Victoria Grey, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
An Australian perspective on antimicrobial stewardship programs and transplantationAdam G Stewart, Burcu Isler, David L Paterson
Jac-Antimicrobial Resistance|July 5, 2021
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant EnterobacteralesDavid L Paterson, Burcu Isler, Patrick N A Harris
The Journal of Antimicrobial Chemotherapy|December 17, 2020
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosaBurcu Isler, Patrick Harris, Adam G Stewart, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
New Treatment Options against Carbapenem-Resistant <i>Acinetobacter baumannii</i> InfectionsBurcu Isler, Yohei Doi, Robert A Bonomo, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidenceBurcu Isler, Zhenya Welyczko, Nicholas Jorgensen, et al.
Expert Review of Anti-Infective Therapy|September 23, 2022
Treatment strategies for OXA-48-like and NDM producing <i>Klebsiella pneumoniae</i> infectionsBurcu Isler, Abdullah Tarık Aslan, Murat Akova, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Modern Rheumatology Case Reports|June 26, 2026
Immunoglobulin A vasculitis in association with invasive meningococcal disease: a case reportJoseph Danicic, Burcu Isler, Jennifer Ng
Current Opinion in Infectious Diseases|February 19, 2020
New treatment options for multiresistant gram negativesDavid L Paterson, Burcu Isler, Adam Stewart
BMC Public Health|February 19, 2020
Limits of the social-benefit motive among high-risk patients: a field experiment on influenza vaccination behaviourOzan Isler, Burcu Isler, Orestis Kopsacheilis, et al.
Infectious Disease Clinics of North America|December 11, 2025
Antimicrobial Management Strategies for Multidrug-Resistant Gram-positive Prosthetic Device InfectionsBurcu Isler, Peter Simos, Victoria Grey, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
An Australian perspective on antimicrobial stewardship programs and transplantationAdam G Stewart, Burcu Isler, David L Paterson
Jac-Antimicrobial Resistance|July 5, 2021
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant EnterobacteralesDavid L Paterson, Burcu Isler, Patrick N A Harris
The Journal of Antimicrobial Chemotherapy|December 17, 2020
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosaBurcu Isler, Patrick Harris, Adam G Stewart, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
New Treatment Options against Carbapenem-Resistant <i>Acinetobacter baumannii</i> InfectionsBurcu Isler, Yohei Doi, Robert A Bonomo, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidenceBurcu Isler, Zhenya Welyczko, Nicholas Jorgensen, et al.
Expert Review of Anti-Infective Therapy|September 23, 2022
Treatment strategies for OXA-48-like and NDM producing <i>Klebsiella pneumoniae</i> infectionsBurcu Isler, Abdullah Tarık Aslan, Murat Akova, et al.
Pageof 4